DE602004028113D1 - Verwendung von 2,3-Dehydronaringenin-Derivaten zur Behandlung von Entzündungsprozessen und diese Derivate enthaltende pharmazeutische Zusammensetzung - Google Patents
Verwendung von 2,3-Dehydronaringenin-Derivaten zur Behandlung von Entzündungsprozessen und diese Derivate enthaltende pharmazeutische ZusammensetzungInfo
- Publication number
- DE602004028113D1 DE602004028113D1 DE602004028113T DE602004028113T DE602004028113D1 DE 602004028113 D1 DE602004028113 D1 DE 602004028113D1 DE 602004028113 T DE602004028113 T DE 602004028113T DE 602004028113 T DE602004028113 T DE 602004028113T DE 602004028113 D1 DE602004028113 D1 DE 602004028113D1
- Authority
- DE
- Germany
- Prior art keywords
- derivatives
- inflammatory processes
- treatment
- dehydronarginine
- pharmaceutical compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04380155A EP1618880B1 (de) | 2004-07-20 | 2004-07-20 | Verwendung von 2,3-Dehydronaringenin-Derivaten zur Behandlung von Entzündungsprozessen und diese Derivate enthaltende pharmazeutische Zusammensetzung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004028113D1 true DE602004028113D1 (de) | 2010-08-26 |
Family
ID=34931855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004028113T Active DE602004028113D1 (de) | 2004-07-20 | 2004-07-20 | Verwendung von 2,3-Dehydronaringenin-Derivaten zur Behandlung von Entzündungsprozessen und diese Derivate enthaltende pharmazeutische Zusammensetzung |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060020021A1 (de) |
| EP (1) | EP1618880B1 (de) |
| AT (1) | ATE473737T1 (de) |
| CA (1) | CA2512531A1 (de) |
| DE (1) | DE602004028113D1 (de) |
| ES (1) | ES2353001T3 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080103103A1 (en) * | 2006-10-30 | 2008-05-01 | Bahram Memarzadeh | Reagents and methods to treat ocular diseases and infection |
| EP2373326B1 (de) * | 2008-12-11 | 2016-03-09 | Axcentua Pharmaceutucals AB | Kristalline formen von genistein |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0725761A (ja) * | 1993-07-09 | 1995-01-27 | Kureha Chem Ind Co Ltd | 軟骨保護剤 |
| JPH08104628A (ja) * | 1994-10-04 | 1996-04-23 | Sumitomo Pharmaceut Co Ltd | マトリックスメタロプロテアーゼ阻害剤 |
| IN186803B (de) * | 1997-02-05 | 2001-11-10 | Panacea Biotec Ltd |
-
2004
- 2004-07-20 DE DE602004028113T patent/DE602004028113D1/de active Active
- 2004-07-20 EP EP04380155A patent/EP1618880B1/de not_active Not-in-force
- 2004-07-20 ES ES04380155T patent/ES2353001T3/es active Active
- 2004-07-20 AT AT04380155T patent/ATE473737T1/de not_active IP Right Cessation
-
2005
- 2005-07-20 US US11/186,121 patent/US20060020021A1/en not_active Abandoned
- 2005-07-20 CA CA002512531A patent/CA2512531A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ATE473737T1 (de) | 2010-07-15 |
| US20060020021A1 (en) | 2006-01-26 |
| ES2353001T3 (es) | 2011-02-24 |
| EP1618880B1 (de) | 2010-07-14 |
| EP1618880A1 (de) | 2006-01-25 |
| CA2512531A1 (en) | 2006-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200900136A1 (ru) | Пирролопиримидины для фармацевтических композиций | |
| DE60325379D1 (de) | Zusammensetzung enthaltend 6-Ä3-(1-adamantyl)-4-methoxyphenylÜ-2-naphthanoesäure zur Behandlung dermatologischer Erkrankungen | |
| IL196543A (en) | Pyridazinone derivatives, pharmaceutical preparations containing them for use in the treatment of disorders | |
| ATE517882T1 (de) | Chinolinderivate | |
| ATE453636T1 (de) | Substituierte 2,3-dihydro-1h-isoindol-1-one derivate und anwendungsverfahren | |
| SE0303180D0 (sv) | Novel compounds | |
| SE0302232D0 (sv) | Novel Compounds | |
| EA201071045A1 (ru) | Соединения оксадиазоантрацена для лечения диабета | |
| SE0301010D0 (sv) | Novel compounds | |
| ATE432278T1 (de) | Verbindungen zur behandlung von krankheiten | |
| NO20063275L (no) | Anvendelse av substituerte 2-aminotetraliner for forebyggende behandling av Parkinsons sykdom | |
| EA200601223A1 (ru) | Производные сульфонамида для лечения заболеваний | |
| SE0301009D0 (sv) | Novel compounds | |
| TW200728305A (en) | Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease | |
| CY1110965T1 (el) | Επιπροσθετες ετεροπολυκυκλικες ενωσεις και η χρηση τους ως ανταγωνιστες μεταβολοτροπικου υποδοχεα γλουταμικου | |
| MXPA03011484A (es) | Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades. | |
| SE0403006D0 (sv) | New compounds | |
| DE602004030222D1 (de) | 2-oxo-1,3,5-perhydrotriazapinderivate, die sich zur behandlung von hyperproliferativen, angiogenen und entzündlichen erkrankungen eignen | |
| TW200616979A (en) | Non-nucleoside reverse transcriptase inhibitors | |
| NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
| ATE538651T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
| EA200970065A1 (ru) | Производные пиперазинила, предназначенные для лечения заболеваний, опосредованных рецептором gpr38 | |
| EP1689713A4 (de) | Benzylether und benzylaminoverbindungen als inhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
| DE602006010738D1 (de) | Pyrroloä2,3-cüpyridinderivate | |
| HK1116477A1 (en) | Benzylpiperazine derivatives useful for the treatment of gastrointestinal disorders |